DexCom, Inc. (DXCM)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about DexCom, Inc. (DXCM)
Go deeper and ask any question about DXCM
Company Performance
Current Price
as of Sep 13, 2024$69.51
P/E Ratio
42.83
Market Cap
$27.85B
Description
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Metrics
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerDXCM
- Price$69.51+1.00%
Trading Information
- Market Cap$27.85B
- Float98.59%
- Average Daily Volume (1m)3,966,463
- Average Daily Volume (3m)5,413,676
- EPS$1.71
Company
- Revenue$3.93B
- Rev Growth (1yr)15.26%
- Net Income$143.50M
- Gross Margin62.40%
- EBITDA Margin20.92%
- EBITDA$210.10M
- EV$46.73B
- EV/Revenue11.88
- P/E42.83
- P/S7.36
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset